Drug Delivery

© Getty Images

Layoffs as Sage Therapeutics reshuffles CNS pipeline

By Jonathan Smith

Less than a month after the U.S. Food and Drug Administration (FDA) gave its antidepressant drug zuranolone (Zurzuvae) a mixed welcome, Sage Therapeutics has launched plans to reorganize its operations by refocusing its drug development efforts and laying...